WHO ICTRP trial
Study on the effectiveness of Ketamine in persons suffering from bipolar…
CTRI/2021/10/037093 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2021/10/037093 |
|---|---|
| Public title | Study on the effectiveness of Ketamine in persons suffering from bipolar depression |
| Scientific title | A randomised clinical study on the effectiveness of Ketamine vs Placebo in the treatment of bipolar depression |
| Primary sponsor | Ahana hospitals LLP |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: F313- Bipolar disorder, current episodedepressed, mild or moderate severity Health Condition 2: F314- Bipolar disorder, current episodedepressed, severe, without psychotic features |
| Interventions | Intervention1: Ketamine infusion: Ketamine is a medication that is used as a short acting anesthetic in pediatric and adult medicine. Sub-anesthetic (low) doses will be given to patients via infusion in order to assess whether it helps with… |
| Registration date | May 10, 2021 |
| Target size | 80 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: